Latest Articles
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer - Yahoo Finance
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer Yahoo Finance
Published: Jan. 21, 2025, 6:43 p.m.
GSK's Jemperli Gets EU Nod for Expanded Use in Endometrial Cancer - Yahoo Finance
GSK's Jemperli Gets EU Nod for Expanded Use in Endometrial Cancer Yahoo Finance
Published: Jan. 21, 2025, 2:35 p.m.
GSK’s Jemperli Gains Expanded EU Approval for Endometrial Cancer - TipRanks
GSK’s Jemperli Gains Expanded EU Approval for Endometrial Cancer TipRanks
Published: Jan. 21, 2025, 12:20 p.m.
Does Chemoradiotherapy Boost Survival in Endometrial Cancer? - Medscape
Does Chemoradiotherapy Boost Survival in Endometrial Cancer? Medscape
Published: Jan. 21, 2025, 9:45 a.m.
EC approves GSK’s Jemperli-chemo combo for endometrial cancer - Pharmaceutical Technology
EC approves GSK’s Jemperli-chemo combo for endometrial cancer Pharmaceutical Technology
Published: Jan. 21, 2025, 9:35 a.m.
GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer - Medical Dialogues
GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer Medical Dialogues
Published: Jan. 21, 2025, 8 a.m.
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer - Indian Pharma Post
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer Indian Pharma Post
Published: Jan. 21, 2025, 4:36 a.m.
Mapping Human Uterine Disorders Through Single-Cell Transcriptomics.
Disruptions in uterine tissue function contribute to disorders such as endometriosis, adenomyosis, endometrial cancer, and fibroids, which all significantly impact health and fertility. Advances in transcriptomics, particularly single-cell RNA sequencing, …
Published: Jan. 21, 2025, midnight
Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer - OncLive
Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer OncLive
Published: Jan. 20, 2025, 9:34 p.m.
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer - Cancer Network
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer Cancer Network
Published: Jan. 20, 2025, 5:08 p.m.
Link copied to clipboard!